|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 51/04 | (2006.01) |
| C07F 9/24 | (2006.01) | ||
| C07F 9/58 | (2006.01) |
| (11) | Number of the document | 2970345 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14721640.2 |
| Date of filing the European patent application | 2014-03-14 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-19 |
| (46) | Date of publication of the claims translation | 2019-09-25 |
| (86) | Number | PCT/US2014/027820 |
| Date | 2014-03-14 |
| (87) | Number | WO 2014/143736 |
| Date | 2014-09-18 |
| (30) | Number | Date | Country code |
| 201361798108 P | 2013-03-15 | US |
| (72) |
BERKMAN, Clifford, US
STEKHOVA, Svetlana, A., US
|
| (73) |
Cancer Targeted Technology LLC,
14241 Woodinville-Duvall Road, Suite 143, Woodinville, WA 98072,
US
Washington State University, Office of Commercialization Washington State University P.O. Box 641802, Pullman, Washington 99164-1802, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | 18F-žymėti pozitronų emisijos tomografijos (PET) vizualizacijos agentai, nukreipti į prostatos atžvilgiu specifinius membranos antigenus (PSMA) |
| 18F-LABELED PSMA-TARGETED PET IMAGING AGENTS |
| Payment date | Validity (years) | Amount | |
| 2026-03-18 | 13 | 433.50 EUR |
| 2027-03-14 |